title: Validated spectrofluorimetric determination of two pharmaceutical antihypertensive mixtures containing amlodipine besylate together with either candesartan cilexetil or telmisartan.
abstract: Amlodipine besylate (AML) is available in fixed-dose combination tablets with either candesartan cilexetil (CAN) or telmisartan (TEL). This work describes a simple, selective and sensitive spectrofluorimetric method for analysis of AML/CAN and AML/TEL binary mixtures without prior separation. The method involves measurement of the native fluorescence of AML at excitation and emission wavelengths of 367 and 454 nm, respectively, in water without interference from either of the two drugs. By contrast, the intrinsic fluorescence of CAN was measured at excitation and emission wavelengths of 265 and 392 nm, respectively, in ethanol, while TEL was measured at 366 nm in 0.05 M sodium hydroxide solution using 294 nm as the excitation wavelength. The proposed spectrofluorimetric procedure was validated with respect to linearity, ranges, precision, accuracy, selectivity, robustness, detection and quantification limits. Regression analysis showed a good correlation between fluorescence intensity and concentration over the ranges 0.1-1.4, 0.025-0.25 and 0.0025-0.05 µg/mL for AML, CAN and TEL, respectively. Limits of detection were 0.034, 0.0063 and 0.0007 µg/mL for AML, CAN and TEL, respectively. The proposed method was successfully applied for the analysis of several synthetic binary mixtures of different ratios and laboratory-prepared tablets with good recoveries, and no interference from common pharmaceutical additives was observed.
authors.affiliation: Department of Pharmaceutical Analytical Chemistry, University of Alexandria, Alexandria, Egypt.
authors.forename: Tarek S
authors.initials: TS
authors.lastname: Belal
authors.forename: Mohamed S
authors.initials: MS
authors.lastname: Mahrous
authors.forename: Magdi M
authors.initials: MM
authors.lastname: Abdel-Khalek
authors.forename: Hoda G
authors.initials: HG
authors.lastname: Daabees
authors.forename: Mona M
authors.initials: MM
authors.lastname: Khamis
mesh_terms: D017311:Amlodipine / Q000737:chemistry*; D000959:Antihypertensive Agents / Q000032:analysis*; D001562:Benzimidazoles / Q000737:chemistry*; D001565:Benzoates / Q000737:chemistry*; D001713:Biphenyl Compounds / Q000737:chemistry*; D002626:Chemistry, Pharmaceutical; D015394:Molecular Structure; D013050:Spectrometry, Fluorescence; D000077333:Telmisartan; D013777:Tetrazoles / Q000737:chemistry*
chemical_list: D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001565:Benzoates; D001713:Biphenyl Compounds; D013777:Tetrazoles; D017311:Amlodipine; C077793:candesartan cilexetil; D000077333:Telmisartan
keywords: amlodipine; candesartan; spectrofluorimetric determination; tablets dosage forms; telmisartan